# Aspirin for Prevention of Postsurgical Recurrence and Metastasis in Asian Colorectal Cancer Patients: a Multi-center Randomized Trial

> **NCT02607072** · PHASE3 · UNKNOWN · sponsor: **The Fourth Affiliated Hospital of Anhui Medical University** · enrollment: 3000 (estimated)

## Conditions studied

- Colorectal Cancer

## Interventions

- **DRUG:** Acetylsalicylic acid (ASA)/aspirin 200 mg daily
- **DRUG:** Acetylsalicylic acid (ASA)/aspirin 100 mg daily
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02607072
- **Lead sponsor:** The Fourth Affiliated Hospital of Anhui Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-10
- **Primary completion:** 2020-10
- **Final completion:** 2022-10
- **Target enrollment:** 3000 (ESTIMATED)
- **Last updated:** 2015-11-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02607072

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02607072, "Aspirin for Prevention of Postsurgical Recurrence and Metastasis in Asian Colorectal Cancer Patients: a Multi-center Randomized Trial". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT02607072. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*